Swansea University
Swansea, Wales, SA28PP, United Kingdom
NCT Number: NCT04566042
A feasibility study to explore whether an acceptance and commitment therapy (ACT) can reduce mental health outcomes (stress, anxiety, depression) and increase psychological flexibility.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Swansea, Wales, SA28PP, United Kingdom
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The intervention is a videogame which teaches the participant about acceptance and commitment therapy.
Time frame: 3 Weeks
Feasibility outcome for recruitment.
Time frame: 3 Weeks
Feasibility outcome for retention of participants.
Time frame: 3 Weeks; Immediate post intervention, and 3-week follow-up
Acceptability of the intervention assessed through qualitative analysis of semi-structured interviews.
Time frame: 3 Weeks; Baseline, immediate post intervention, and 3-week folllow-up
Quantitative psychometric measure for depression. Score Range: Min=0, Max=21. Higher scores indicate higher depression.
Time frame: 3 Weeks; Baseline, immediate post intervention, and 3-week folllow-up
Quantitative psychometric measure for anxiety. Score Range: Min=0, Max=21. Higher scores indicate higher anxiety.
Time frame: 3 Weeks; Baseline, immediate post intervention, and 3-week folllow-up
Quantitative psychometric measure for stress. Score Range: Min=0, Max=21. Higher score indicate higher stress.
Time frame: 3 Weeks; Baseline, immediate post intervention, and 3-week folllow-up
Quantitative psychometric measure for psychological inflexibility. Score Range: Min=7, Max=49. Higher scores indicate higher psychological inflexibility.
Time frame: 3 Weeks; Baseline, immediate post intervention, and 3-week folllow-up
Quantitative psychometric measure of Social Connectedness. Score range: Min=2, Max=8. Higher scores indicate higher social connectedness.
Time frame: 3 Weeks; Baseline, immediate post intervention, and 3-week folllow-up
Quantitative psychometric measure of mental well-being with a focus on positive aspects of mental health. Score Range: Min=14, Max=70. Higher scores indicate higher wellbeing.
Time frame: 3 Weeks; Baseline, immediate post intervention, and 3-week folllow-up
Score Range: Min=1, Max=5. Higher scores indicate lower mobility.
Time frame: 3 Weeks; Baseline, immediate post intervention, and 3-week folllow-up
Score Range: Min=1, Max=5. Higher scores indicate lower self-care.
Time frame: 3 Weeks; Baseline, immediate post intervention, and 3-week folllow-up
Score Range: Min=1, Max=5. Higher scores indicate lower partaking in usual activities.
Time frame: 3 Weeks; Baseline, immediate post intervention, and 3-week folllow-up
Score Range: Min=1, Max=5. Higher scores indicate lower pain/discomfort.
Time frame: 3 Weeks; Baseline, immediate post intervention, and 3-week folllow-up
Score Range: Min=1, Max=5. Higher scores indicate lower anxiety/depression.
Time frame: 3 Weeks; Baseline, immediate post intervention, and 3-week folllow-up
Score Range: Min=0, Max=100. Higher scores indicate higher health.
Swansea University
Other
A Novel ACT-based Video Game to Support Mental Health Through Embedded Learning: A Mixed-methods Feasibility Study Protocol
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05478941
Anxiety, Anxiety Disorders
Padova, Italy
View Trial DetailsNCT04595084
Alcohol Drinking, Alcohol Use, Unspecified
Cambridge, Massachusetts, United States
View Trial DetailsNCT07272096
Anxiety, Anxiety Disorders
Swansea, Wales, United Kingdom
View Trial DetailsNCT05506644
Anxiety, Anxiety Disorders
San Diego, California, United States
View Trial Details